BofA lowered the firm’s price target on Icon (ICLR) to $170 from $195 and keeps a Buy rating on the shares. The new administration’s policy changes and positions have created further uncertainty, resulting in a soft start to FY25, says the analyst, who believes limited visibility in the near-term and macro challenges will remain an overhang for Contract Research Organizations in coming quarters. Given that view, the analyst trimmed estimates for most of the firm’s CRO coverage universe, but adds that even with lower estimates, current CRO valuations “remain attractive and are close to their all-time lows compared to historic levels.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- ICON plc Schedules Q2 2025 Earnings Call
- ICON plc Reports Strong Interim Financial Results for Early 2025
- ICON plc Announces 2025 AGM and Key Resolutions
- Icon’s Promising Medium to Long-Term Growth Prospects Justify Buy Rating Despite Near-Term Challenges
- ICON plc to Present at William Blair Growth Stock Conference